or Try an Advanced Search...

    Technical Analysis for IDYA - IDEAYA Biosciences, Inc.

    Grade Last Price % Change Price Change
    D 42.44 1.53% 0.64
    IDYA closed up 1.53 percent on Wednesday, May 15, 2024, on 1.17 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
    Earnings due: May 31
    *** please verify all earnings dates ***
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical IDYA trend table...
    Date Alert Name Type % Chg
    Shooting Star Candlestick Bearish 0.00%
    Lizard Bearish Bearish Day Trade Setup 0.00%
    Crossed Above 50 DMA Bullish 0.00%
    MACD Bullish Centerline Cross Bullish 0.00%
    Doji - Bearish? Reversal 0.00%
    Gapped Up Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Outside Day Range Expansion 1.53%
    180 Bearish Setup Bearish Swing Setup 3.34%
    NR7 Range Contraction 3.34%
    Older End-of-Day Signals for IDYA ...

       Recent Intraday Alerts

    Alert Time
    1.5x Volume Pace about 17 hours ago
    Up 5% about 17 hours ago
    Upper Bollinger Band Resistance about 17 hours ago
    60 Minute Opening Range Breakout about 17 hours ago
    Rose Above Upper Bollinger Band about 17 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    IDYA Chart by TradingView
    Basic chart:

    Profile

    IDEAYA is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. IDEAYA's approach integrates capabilities in identifying and validating translational biomarkers with small molecule drug discovery to select patient populations most likely to benefit from the targeted therapies IDEAYA is developing. IDEAYA is applying these capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality – which represents an emerging class of precision medicine targets.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Clinical Medicine Drug Discovery Medical Genetics Biomarkers Medical Test Precision Medicine Molecular Diagnostics Targeted Therapy Systems Biology Synthetic Lethality

    Is IDYA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 8 IDEAYA Biosciences First Quarter 2024 Earnings: US$0.53 loss per share (vs US$0.49 loss in 1Q 2023)
    May 7 IDEAYA Biosciences Inc (IDYA) Reports Q1 2024 Earnings: Financial and Strategic Developments
    May 7 IDEAYA Biosciences GAAP EPS of -$0.53 misses by $0.01
    May 7 IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
    May 1 IDEAYA Biosciences to Participate in Upcoming May 2024 Investor Relations Event
    Apr 24 IDEAYA Biosciences Announces ASCO 2024 Oral Presentation for Darovasertib in Neoadjuvant Uveal Melanoma Phase 2 Investigator Sponsored Study
    Apr 22 IDEAYA Biosciences Announces Selection of Move-Forward Phase 2 Expansion Dose for IDE397 Monotherapy in MTAP-Deletion Squamous Non-Small Cell Lung Cancer
    Apr 5 IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    Apr 1 IDEAYA Biosciences to Participate in Upcoming April 2024 Investor Relations Event
    Mar 27 TipRanks’ ‘Perfect 10’ List: These 3 Top-Scoring Stocks Are Sending a Bullish Signal
    See more IDYA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 47.735
    52 Week Low 20.845
    Average Volume 653,590
    200-Day Moving Average 35.06
    50-Day Moving Average 42.18
    20-Day Moving Average 40.51
    10-Day Moving Average 41.80
    Average True Range 1.62
    RSI (14) 55.36
    ADX 14.17
    +DI 28.03
    -DI 16.54
    Chandelier Exit (Long, 3 ATRs) 39.29
    Chandelier Exit (Short, 3 ATRs) 41.44
    Upper Bollinger Bands 43.91
    Lower Bollinger Band 37.12
    Percent B (%b) 0.78
    BandWidth 16.77
    MACD Line 0.06
    MACD Signal Line -0.17
    MACD Histogram 0.2341
    Fundamentals Value
    Market Cap 3.06 Billion
    Num Shares 72.1 Million
    EPS -1.98
    Price-to-Earnings (P/E) Ratio -21.43
    Price-to-Sales 140.95
    Price-to-Book 6.52
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 45.55
    Resistance 3 (R3) 45.77 44.96 45.03
    Resistance 2 (R2) 44.96 44.17 44.85 44.85
    Resistance 1 (R1) 43.70 43.68 43.30 43.48 44.68
    Pivot Point 42.89 42.89 42.69 42.78 42.89
    Support 1 (S1) 41.63 42.10 41.23 41.41 40.20
    Support 2 (S2) 40.82 41.61 40.71 40.03
    Support 3 (S3) 39.56 40.82 39.85
    Support 4 (S4) 39.34